News

UK vehicle production continues to face constraints, with figures from the Society of Motor Manufacturers and Traders (SMMT) ...
Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the 30 stocks expected to beat the market by 20 percentage points this ...
The new car market recorded its second consecutive month of growth in June, with registrations rising 6.7% year-on-year ...
Summit Therapeutics (SMMT) stock gains as AstraZeneca (AZN) is said to eye its lung cancer drug ivonescimab, a potential ...
Fintel reports that on July 1, 2025, UBS initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Buy recommendation.
Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...
SMMT registration figures show that 47,354 BEVs were registered last month, taking the total for the first six months of the ...
Tesla's new car sales in Britain rose year-on-year in June amid a broader recovery in the electric-vehicle market, data ...
Summit Therapeutics Inc. (NASDAQ: SMMT) is one of the best hot stocks to buy according to Wall Street analysts. On July 3, ...
The Jurassic Coast ranks among the UK’s top electric vehicle-friendly road trips, with 73 public charging points, stunning ...
Tesla sold 7,719 units in June, up 14% from a year earlier, according to the SMMT. Data from the research group New ...